The Cost Crisis of Weight Loss Drugs

Send us a textGLP-1 medications like Novo Nordisk's Wegovy and Ozempic are taking the market by storm.With demand soaring, many patients are realizing these medications are either not being covered or simply too expensive.Is this all due to provider greed or is the issue more complicated?In this episode of CareTalk, David E. Williams and John Driscoll discuss how the growing demand for weight-loss drugs is creating a conundrum for providers, forcing them to decide between avoiding the costs a...

Om Podcasten

CareTalk: Healthcare. Unfiltered. is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. Visit us at www.CareTalkPodcast.com